The E-Cigarette Revolution: ASH Survey Finds More Smokers Quitting

Aug.30.2022
The E-Cigarette Revolution: ASH Survey Finds More Smokers Quitting
Electronic cigarettes have helped 1/5th of smokers quit, but ASH warns they should not replace efforts to address smoking.

A survey by anti-smoking organization ASH (Action on Smoking and Health) has revealed a true "electronic cigarette revolution" in the world over the past decade. Approximately 8.3% of people in the UK frequently use e-cigarettes. However, ASH's Deputy Chief Executive Hazel Cheeseman believes that electronic devices have become a lifeline for those desperately trying to quit regular cigarettes. According to the organization, of the 4.3 million e-cigarette users, approximately 2.4 million are former smokers.


Over 13,000 UK adults participated in the company's annual survey. The results showed that one in five smokers used e-cigarettes to assist with smoking cessation. Additionally, more than half of the respondents (56%) switched to using e-cigarettes over three years ago.


However, currently, 28% of smokers said they have never tried electronic cigarettes. 21% of respondents refuse to switch one addiction for another. Others believe that electronic cigarettes are not like smoking regular cigarettes, or have found modern devices to be more harmful.


As pointed out by an employee of ASH, the issue of smoking has not been completely resolved by alternative solutions. Furthermore, e-cigarettes are particularly popular among young people and there is a growing trend of children aged 11 to 17 purchasing them by 2022. Despite the law prohibiting the sale of e-cigarettes to those under 18 years old.


We cannot rely on e-cigarettes to fully solve the smoking problem. We must make greater efforts to meet this challenge. It is now time for the government to take action," added Kisman.


According to annual population survey data, the smoking rate among adults aged 18 and over in the country declined from 20% in 2011 to 14% in 2019. According to an ASH report, e-cigarettes were the reason for an increase in the number of smokers quitting in the UK in 2017.


Announcement:


This article has been compiled based on information from a third-party source and is intended for industry professionals to exchange and learn from.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the veracity and accuracy of its content. The translation of this article is intended for industry exchange and research purposes only.


Due to limitations in translation, the translated article may not fully represent the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any stance or position related to domestic, Hong Kong, Macau, Taiwan, and foreign issues.


The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on Tuesday in a case brought by seven small vape-liquid companies challenging the Food and Drug Administration’s denial of marketing authorization for their flavored electronic nicotine products.
Apr.30 by 2FIRSTS.ai
Jeju Health Center to Apply Conventional Tobacco Rules to Liquid E-Cigarettes From April 24
Jeju Health Center to Apply Conventional Tobacco Rules to Liquid E-Cigarettes From April 24
Jeju Health Center said it will apply the same regulations used for conventional tobacco products to all tobacco products, including liquid e-cigarettes, from April 24, while also strengthening public guidance and smoke-free zone management.
Apr.21 by 2FIRSTS.ai
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
New York’s Lawsuit Against Puff Bar and Other Flavored Vape Companies Survives Key Court Challenge
According to Law360, a federal judge ruled that makers and distributors of flavored vape brands such as Puff Bar cannot escape New York’s lawsuit seeking to hold them responsible for the youth vaping epidemic. The court found that the state had adequately alleged the companies misrepresented how safe vaping is.
Apr.07 by 2FIRSTS.ai
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY
Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY
Japanese Tobacco (JT) reports Q1 2026 revenue of 924 billion yen, a 15.2% increase; operating profit rises 24.7%.
May.08 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai